Wendy Phillips Kaleem Munazzah Asad Rehman Robert Keller
HCA Healthcare
01-01-2026
BACKGROUND Acute pancreatitis (AP) has become one of the leading gastrointestinal diagnoses resulting in inpatient hospitalization¹. AP is diagnosed by meeting two of three criteria: characteristic cl..
BACKGROUND Acute pancreatitis (AP) has become one of the leading gastrointestinal diagnoses resulting in inpatient hospitalization¹. AP is diagnosed by meeting two of three criteria: characteristic clinical presentation, biochemical evidence (elevated lipase or amylase levels), and imaging findings with pancreatic inflammation. Gallstones and heavy alcohol use account for most cases (40%–70% and 25%–35%, respectively). Hypertriglyceride induced AP (HTG-AP) accounts for only about 7-10% of AP cases³ and often tends to present in younger, male, obese, patients with a higher rate of diabetes¹. Below we present a unique case of a coinciding alcoholic and HTG - AP in an otherwise healthy female and discuss the importance of early diagnosis and appropriate treatment. CASE DESCRIPTION The patient is a 56-year-old woman with a history of alcohol use disorder and scoliosis who presented with epigastric pain, nausea, and vomiting. She reported drinking twelve 12-oz beers daily and had one prior hospitalization for alcohol-related pancreatitis earlier this year. Lipase on admission was 632 U/L, and abdominal MRI showed peripancreatic edema consistent with AP. Her alcohol level was elevated which further supported alcoholic pancreatitis. To complete the AP workup, triglyceride (TG) level was collected and found to be markedly elevated at 2740 mg/dL. The patient was promptly admitted and started on an insulin drip with 87% TG reduction within 24 hours. She was then transitioned to fenofibrate and discharged on orlistat, fenofibrate, and dietary modifications. DISCUSSION Patients with HTG-AP are at higher risk for severe disease progression and complications, including respiratory and circulatory failure, compared with other etiologies⁴. While plasmapheresis was traditionally the mainstay of treatment, recent evidence supports early insulin therapy, which achieves similar clinical outcomes with fewer adverse events and lower costs⁵. After TGs are reduced to